J. Goldman & Co’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,400	Closed	-$245K	–	398
2024 Q3	$245K	Hold	5,400	–	–	0.01%	293
2024 Q2	$226K	Buy	+5,400	New	+$226K	0.01%	280